Please login to the form below
Henrik Stenqvist joins Recipharm
Was previously CFO for Meda Group
Recipharm appoints Henrik Stenqvist as its new executive VP and chief financial officer, bringing 24 years of finance and management experience.
He said: “I’m looking forward to contributing to the continued success of Recipharm in my new capacity as chief financial officer of this leading company.”
Prior to joining Recipharm, Stenqvist served as CFO for Meda Group and has held other finance positions in the pharmaceutical industry.
Thomas Eldered, CEO of Recipharm, said: “I am very pleased to welcome Henrik, his extensive experience and perspectives in finance, business and strategic development in the pharmaceutical industry make him a great fit for Recipharm as we continue on our strong growth path.”
Stenqvist will be based at the company’s headquarters in Stockholm, Sweden where he will focus on financial planning and reporting.
Featured jobs
- Engagement Expert, Healthcare Brand Communications, London
-
Excellent package
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
-
Account Director, Medical Education
-
Salary TBC
-
Senior Account Manager
-
Competitive Salary Offered
-
Associate Director
-
£75, 000-90, 000
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
-
Business Director
-
Competitive Salary Offered
-
Senior Medical Writer
-
Salary TBC
-
Account Manager / Account Director
-
Competative
-
Medical Writer
-
Salary TBC
- Global Business Development Director – Health Education
-
excellent commission
- Account Manager / Senior Account Manager
-
35, 000-40, 000
-
Account Director
-
Competitive Salary Offered
- Senior Account Manager, Rare Diseases – Medical Communications, ...
-
Excellent package
- Senior Account Director development role to Business Director, H...
-
Excellent package
Subscribe to our email news alerts
- Pfizer takeover rumour ignites Amarin shares
- Welcome to the Communique Awards - Communiqué Awards 2018
- NICE rejects Novartis migraine treatment Aimovig
- GSK upbeat on its return to oncology market
- AstraZeneca unveils reorg, hires controversial José Baselga as cancer chief
- AZ’s Sean Bohen to exit after business overhaul; report
- China approves Ironwood Pharma’s IBS treatment
- FDA expecting boom in cell and gene therapies
- Industry pleads for compromise after Brexit defeat
- The new UK government-pharma industry pricing agreement – welcome news, but there are lessons to be learnt
- The UK’s new five-year pricing agreement
- Lucid kick-starts 2019 with spellbinding new additions to its writing and account teams
PMHub
Hanson Zandi
Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...
Latest intelligence
- The new UK government-pharma industry pricing agreement – welcome news, but there are lessons to be learnt
- ...
- The UK’s new five-year pricing agreement
- Pharma has agreed to capped growth again – in exchange for uptake promises...
- Digital applications are transforming the market access landscape
- Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Quick links
Infographics
